Io Biotech(OTC) IOBTQ

Market Cap$143.90K

Since IPO (2021)-100%

5 YearN/A

1 Year-100%

1 Month-62%

$0.00

+0.00%

+0.00Today

Io Biotech last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-10

Io Biotech stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+900%	USD 0.00	2026-08-03
1 month	-62.09%	USD 0.01	2026-07-10
3 month	-54.55%	USD 0.00	2026-05-12
Year to date	-99.67%	USD 0.61	2025-12-31
1 year	-99.89%	USD 1.81	2025-08-08
3 year	-99.89%	USD 1.83	2023-08-11
Since inception	-99.99%	USD 15.65	2021-11-05

Io Biotech Financials at a Glance

Market Cap

$143.90K

Revenue (TTM)

$0.00

Net Income (TTM)

-$88.35

EPS (TTM)

-$1.34

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.00

Volume

1,500

Open

$0.00

Price

$0.00

Volume

1,500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $2.79

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.00

Volume

1,500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $2.79

Estimated Earnings Date

N/A

IOBTQ News

Io Biotech Posts Wider Loss in Q2

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Io Biotech

IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. The company was founded by Mai-Britt Zocca, Inge Marie Svane, and Mads Hald Andersen in December 2014 and is headquartered in Copenhagen, Denmark.

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Mai-Britt Zocca, PhD

Website

www.iobiotech.com

IOBTQ Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-240.48%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$143.90K

Shares Outstanding

71.95M

Volume

1.50K

Avg. Volume

313.76K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Io Biotech Performance Analysis

Io Biotech annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 0	N/A
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 0	N/A

Io Biotech annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -2.60	N/A
2022	2022-12-31	USD -2.48	-4.7%
2023	2023-12-31	USD -1.98	-20.3%
2024	2024-12-31	USD -1.45	-26.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$0.23

+1.1%

Gross Margin

N/A

Market Cap

$143.90K

N/A

Market Cap/Employee

$0.31

N/A

Employees

N/A

Net Income

-$8.38

+0.3%

EBITDA

-$19.13

+0.7%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Total Cash

$48.78

-40.7%

Total Debt

$18.12

+9.0%

Accounts Receivable

N/A

Inventory

$0.00

N/A

Long Term Debt

$17.33

+13.1%

Short Term Debt

$0.79

+1.1%

Return on Assets

-136.03%

+2.0%

Return on Invested Capital

-161.42%

-6.7%

Free Cash Flow

-$18.48

+0.9%

Operating Cash Flow

-$18.48

+0.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,720.28-0.00%

^DJIDJI

^DJIDJI$53,833.46-0.00%

^IXICNASDAQ

^IXICNASDAQ$26,389.23-0.01%

BTCBitcoin

BTCBitcoin$63,536.00-0.01%

SPCXSPCX

SPCXSPCX$130.82-0.06%

AAPLAAPL

AAPLAAPL$304.91-0.01%

AMZNAMZN

AMZNAMZN$272.31-0.02%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SMCISuper Micro Computer

SMCISuper Micro Computer$36.05+0.14%

INTCIntel

INTCIntel$100.58+0.03%

NOKNokia

NOKNokia$10.33+0.09%

CRWVCoreWeave

CRWVCoreWeave$108.18+0.20%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$139.23+0.04%

NVDANvidia

NVDANvidia$222.97+0.03%

NBISNebius Group

NBISNebius Group$233.79+0.21%

Questions About IOBTQ

What is the current price of Io Biotech?

Io Biotech is trading at $0.00 per share.

What is the 52-week range for Io Biotech?

Over the past 52 weeks, Io Biotech has traded between $0.00 and $2.79.

How much debt does Io Biotech have?

As of the most recent reporting period, Io Biotech reported total debt of $18.12M.

How much cash does Io Biotech have on hand?

Io Biotech reported $30.66M in cash and cash equivalents in its most recent financial results.

What is Io Biotech’s dividend yield?

Io Biotech does not currently have a dividend yield.

Io Biotech(OTC) IOBTQ

Io Biotech Financials at a Glance

IOBTQ News

Io Biotech Posts Wider Loss in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Io Biotech

IOBTQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Io Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IOBTQ

What is the current price of Io Biotech?

What is the 52-week range for Io Biotech?

How much debt does Io Biotech have?

How much cash does Io Biotech have on hand?

What is Io Biotech’s dividend yield?

Premium Investing Services